ClinicalTrials.Veeva

Menu

Pharmacist Role in HF Patients Transition of Care

Nova Southeastern University (NSU) logo

Nova Southeastern University (NSU)

Status

Withdrawn

Conditions

Heart Failure

Treatments

Behavioral: Pharmacist intervention

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To assess the effectiveness of pharmacist's provided education in HF patients, in improving patients' knowledge and self-efficacy, and to assess the impact of this intervention on the rate of hospital readmission and emergency visits at 30-days, 60-days and 90-days after discharge.

Full description

"Transition of care" is one of the new disciplines that pharmacists have been involved-in within the healthcare system. It is a process where a patient's care is shifting from one setting to another. During this process, transitional care is designed to ensure continuity of patient care across different sites or across different levels of care within the same facility. For example, from Intensive Care Unit (ICU) to the ward, from hospital to home, or from hospital to rehab centers. Many stakeholders are involved in this process, and coordination between them is necessary to have successful one, in addition to logistical arrangements, and patient education. Otherwise, poor communication, inadequate patient education, and lack of access to healthcare services, will produce failure of having a smooth transition and could result in negative health outcomes including complications in the patient's disease status, emergency room visits or hospital readmissions. Not only that these negative health outcomes are affecting the patient, they are also negatively affecting the healthcare spending in the United States. For instance, inadequate care coordination and management of care transitions accounted for $25 to $45 billion in wasteful spending in 2011 through preventable adverse events and hospital readmissions. Therefore, cost containment and reducing the excessive spending in healthcare is an important aim of "transition of care", secondary to improving patient outcomes.

Pharmacist's role in Transition of care:

Pharmacists have the knowledge, training and expertise to play a major role in the transition of care process. They are involved in dispensing the patient's medications at the hospital, ensuring that the patient's medication chart is updated, identify any medication discrepancy, provide medication reconciliation, medication education, patient counseling at discharge and they could follow-up with the patients after discharge to check if they filled their prescription, what side effects are they having, and monitor their adherence to their treatment plan. These pharmacist's interventions have been applied, among other approaches, by hospitals to improve the quality of their services and minimize the rate of readmissions.

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admitted HF patients at WKBH
  • Patients with primary or secondary diagnosis of HF
  • Discharged to Home
  • 18 years old or older

Exclusion criteria

  • ≥ 90 years old
  • Patients with major comorbidities such as cancer, end-stage kidney disease, and liver failure
  • Patients with memory problems such as dementia and Alzheimer's disease
  • Patients discharged to places other than home
  • Patients who are unable to understand or follow discharge instructions

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

Pharmacist intervention group
Experimental group
Description:
The intervention group will receive: 1. A phone call 48h-72h after discharge from the hospital to ensure that the patient filled their prescriptions and started taking their medication. 2. A phone call five to seven days after discharge to reinforce the education using the "teach back technique"1. Patients will be asked about their medications, what are they for, how to use them, and what side effects to watch for, based on the education and information that was provided to them at discharge.
Treatment:
Behavioral: Pharmacist intervention
usual care group
No Intervention group
Description:
The control group will receive the usual standard care available at West Kendall Baptist Hospital.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems